CRIS compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name

CRISCuris Inc

Mkt capRevenueRevenue

AMGNAmgen Inc

Mkt capRevenueRevenue

Compare

CRISCuris Inc

AMGNAmgen Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

CRIS: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only CRIS 1

—Genentechunlistedcustomer

Shared 0

No shared counterparties.

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

8 more · AMGN chain ›

CRISCuris Inc

1.11· pre 0.90· delayed

Mkt cap$1.5MRevenue$1MQ4 FY25Revenue$9MFY25

AMGNAmgen Inc

478.34· pre 479.89· delayed

Pre-marketNov 5 '26delayed

Mkt cap$258.8BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

Compare

Pre-marketNov 5 '26delayed

CRISCuris Inc

AMGNAmgen Inc

1.11pre 0.90delayed

Price

478.34pre 479.89delayed

$1.5M

Mkt cap

$258.8B

Q4 FY25$1M

Revenue

$10.4BQ3 FY26

FY25$9M

Revenue

$36.8BFY25

CRIS1.11vsAMGN478.34Pre-marketNov 5 '26delayed

Price

rebased to 0%

CRIS, solidAMGN, dashed